Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury

TAK-875 (fasiglifam), a GPR40 agonist in development for the treatment of type 2 diabetes (T2D), was voluntarily terminated in Phase III trials due to adverse liver effects. The potential mechanisms of TAK-875 toxicity were explored by combining in vitro experiments with quantitative systems toxicol...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Diane M, Woodhead, Jeffrey L, Walker, Paul, Herédi-Szabó, Krisztina, Mogyorósi, Károly, Wolenski, Francis S, Dragan, Yvonne P, Mosedale, Merrie, Siler, Scott Q, Watkins, Paul B, Howell, Brett A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Tak-875 Liver Injury: Bile Acid and Mitochondrial Effects
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358270/
https://www.ncbi.nlm.nih.gov/pubmed/30289550
http://dx.doi.org/10.1093/toxsci/kfy253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358270/
https://www.ncbi.nlm.nih.gov/pubmed/30289550
http://dx.doi.org/10.1093/toxsci/kfy253

Ejemplares similares